[Remote] Pharmaceutical Sales - Territory Manager - Dermatology Specialty at Eli Lilly and Company

Chester, Maryland, United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Full time employment
Experience in account-based selling to healthcare providers (HCPs)
Understanding of the healthcare environment and reimbursement landscape
Ability to build relationships with key stakeholders
Strong communication and interpersonal skills
Ability to understand clinical information and disease states
Learning agility
Patient-centered approach

Responsibilities

Account-based selling to HCPs in dermatology practices and hospital accounts
Building relationships with key customers, advocacy groups, teaching institutions, and managed care organizations
Driving adoption of Lilly's new and existing therapies
Developing a strong understanding of territory and reimbursement landscape
Analyzing business insights tools to adapt to business needs
Promoting the entire product portfolio
Utilizing selling model to identify appropriate patients
Meeting sales goals while adhering to internal policies and procedures
Collaborating effectively with partners

Skills

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free